XRCC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.509200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.490000E-01
Normal-vs-Stage2
9.214000E-01
Normal-vs-Stage3
3.517200E-01
Normal-vs-Stage4
4.886600E-01
Stage1-vs-Stage2
5.086800E-01
Stage1-vs-Stage3
6.110600E-01
Stage1-vs-Stage4
2.174400E-01
Stage2-vs-Stage3
2.536000E-01
Stage2-vs-Stage4
4.159800E-01
Stage3-vs-Stage4
1.547820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.043600E-01
Normal-vs-AfricanAmerican
7.092600E-01
Normal-vs-Asian
9.438200E-01
Caucasian-vs-AfricanAmerican
3.104600E-01
Caucasian-vs-Asian
5.356800E-01
AfricanAmerican-vs-Asian
7.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.140200E-01
Normal-vs-Female
9.053000E-01
Male-vs-Female
6.627800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.376200E-01
Normal-vs-Age(41-60Yrs)
7.838600E-01
Normal-vs-Age(61-80Yrs)
7.079400E-01
Normal-vs-Age(81-100Yrs)
7.704000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.287180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.095800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.266200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.385700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.472200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.347400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.637400E-01
Normal-vs-Daily Drinker
5.141000E-01
Normal-vs-Weekly Drinker
9.439600E-01
Normal-vs-Occasional Drinker
6.480400E-01
Normal-vs-Social Drinker
7.575000E-01
Non Drinker-vs-Daily Drinker
9.584400E-01
Non Drinker-vs-Weekly Drinker
3.282200E-01
Non Drinker-vs-Occasional Drinker
2.147900E-02
Non Drinker-vs-Social Drinker
4.917200E-01
Daily Drinker-vs-Weekly Drinker
3.779400E-01
Daily Drinker-vs-Occasional Drinker
4.126200E-02
Daily Drinker-vs-Social Drinker
5.247200E-01
Weekly Drinker-vs-Occasional Drinker
4.585600E-01
Weekly Drinker-vs-Social Drinker
7.624200E-01
Occasional Drinker-vs-Social Drinker
1.982830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.994590E-01
Normal-vs-Grade 2
1.708400E-02
Normal-vs-Grade 3
1.180120E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.461200E-03
Grade 1-vs-Grade 3
2.795700E-03
Grade 1-vs-Grade 4
1.994590E-01
Grade 2-vs-Grade 3
5.775400E-01
Grade 2-vs-Grade 4
1.708400E-02
Grade 3-vs-Grade 4
1.180120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.923600E-01
Normal-vs-NonDiabetic
8.267400E-01
Diabetic-vs-NonDiabetic
3.194000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.750600E-01
Normal-vs-NoPancreatitis
7.853600E-01
Pancreatitis-vs-NoPancreatitis
5.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.898200E-01
Normal-vs-N1
9.201400E-01
N0-vs-N1
6.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.813600E-01
Normal-vs-TP53-NonMutant
6.178800E-01
TP53-Mutant-vs-TP53-NonMutant
4.05849999995933E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
